SBX

XETRA:SBX

SynBiotic SE

  • Stock

EUR

Last Close

7.96

26/07 15:36

Market Cap

42.51M

Beta: 5.34

Volume Today

2.71K

Avg: 15.08K

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
262.38K
-
1.97M
652.14%
3.39M
71.54%
average payables
460.77K
-
2.81M
510.29%
3.34M
18.71%
average receivables
474.69K
-
862.47K
81.69%
658.48K
23.65%
book value per share
0.94
-
16.32
1,637.80%
11.41
30.07%
capex per share
-1.37
-
-0.12
91.29%
capex to depreciation
-17.84
-
-0.04
99.75%
-0.03
41.26%
capex to operating cash flow
1.69
-
0.07
95.80%
0.07
3.83%
capex to revenue
-0.39
-
-0.04
89.67%
-0.06
45.17%
cash per share
3.87
-
1.71
55.85%
days of inventory on hand
110.51
-
323.34
192.59%
266.06
17.71%
days payables outstanding
194.07
-
444.30
128.94%
156.84
64.70%
days sales outstanding
63.32
-
31.23
50.68%
24.20
22.51%
debt to assets
0.00
-
0.02
375.34%
0.11
602.93%
debt to equity
0.00
-
0.03
499.28%
0.20
629.42%
dividend yield
earnings yield
-0.00
-
-0.00
10,062.87%
-0.03
953.87%
-0.15
464.35%
enterprise value
5.47M
-
28.05M
412.62%
87.29M
211.15%
3.49M
96.01%
enterprise value over ebitda
-407.52
-
-46.53
88.58%
-17.68
62.01%
-0.57
96.77%
ev to operating cash flow
-22.21
-
-16.97
23.58%
-0.50
97.06%
ev to sales
5.13
-
9.63
87.86%
0.43
95.57%
free cash flow per share
-2.18
-
-1.80
17.50%
free cash flow yield
-0.10
-
-0.06
38.41%
graham net net
-0.01
-
-1.61
16,062.09%
-5.34
232.05%
graham number
1.06
-
14.39
1,253.30%
33.08
129.91%
income quality
1.44
-
0.39
72.57%
0.27
31.63%
intangibles to total assets
0
-
0
0.76
Infinity%
0.71
7.15%
0.66
5.93%
interest coverage
-31.60
-
-284.14
799.28%
-130.32
54.14%
interest debt per share
0.09
-
0.32
266.73%
inventory turnover
3.30
-
1.13
65.82%
1.37
21.53%
invested capital
0.00
-
0.03
499.28%
0.20
629.42%
market cap
34.04M
-
5.47M
83.92%
34.04M
522.08%
89.55M
163.05%
net current asset value
235.75K
-
-1.84M
879.63%
-13.34M
625.65%
-9.79M
26.61%
net debt to ebitda
9.94
-
0.46
95.39%
-0.57
224.53%
net income per share
-0.00
-
-0.05
10,062.87%
-0.56
953.87%
-4.26
655.92%
operating cash flow per share
-0.81
-
-1.68
107.33%
payables turnover
1.88
-
0.82
56.32%
2.33
183.29%
receivables turnover
5.76
-
11.69
102.76%
15.08
29.05%
research and ddevelopement to revenue
return on tangible assets
-0.06
-
-0.10
86.08%
-0.73
598.83%
-1.79
143.61%
revenue per share
3.50
-
2.96
15.66%
roe
-0.06
-
-0.03
39.36%
-0.37
980.98%
-1.08
188.76%
roic
-0.06
-
-0.03
49.19%
-0.35
1,114.73%
-0.88
150.46%
sales general and administrative to revenue
0.13
-
shareholders equity per share
0.94
-
16.32
1,637.80%
11.41
30.07%
stock based compensation to revenue
tangible asset value
235.75K
-
-1.14M
582.17%
-6.09M
435.91%
-4.19M
31.21%
tangible book value per share
0.94
-
-0.73
177.51%
-1.99
172.88%
working capital
238.25K
-
-1.77M
842.51%
3.36M
289.73%
2.31M
31.28%

All numbers in EUR (except ratios and percentages)